BALTIMORE--(BUSINESS WIRE)--Profectus BioSciences, Inc. (Profectus), a clinical stage biopharmaceutical company focused on the development of novel vaccine candidates for chronic viral infections, announced today that the company will speak on two industry panels, as well as give a company presentation at the 2009 BIO International Convention. The conference is taking place in Atlanta, GA from May 18-21, 2009. The company is available to schedule one-on-one partnering meetings through the BIO Business Forum. For more information about the conference or to schedule a meeting, please visit http://convention.bio.org/.
